Products

Cnidii Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Cnidii Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: Cnidii Fructus Vet API
    • Einecs: 90674-94-5
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    274194

    Product Name Cnidii Fructus Veterinary Grade API
    Appearance Brown to yellowish-brown powder
    Active Ingredient Osthole
    Purity ≥98%
    Source Cnidium monnieri (L.) Cusson
    Intended Use Veterinary pharmaceuticals
    Dosage Forms Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions
    Application Antiparasitic, antifungal, and anti-itch agent
    Solubility Slightly soluble in water, freely soluble in alcohol
    Storage Conditions Cool, dry place away from direct sunlight
    Shelf Life 2 years
    Packing Double-layer plastic bag with fiber drum
    Country Of Origin China

    As an accredited Cnidii Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Packed in 25kg fiber drums with double-layer polyethylene bags inside, ensuring moisture protection and product integrity for veterinary use.
    Shipping Shipping for **Cnidii Fructus Veterinary Grade API** is conducted in sealed, tamper-proof, pharmaceutical-grade packaging to ensure product stability during transit. Packages are labeled and compliant with international regulations. Fast and secure delivery is available by air or sea, with temperature and moisture controls as needed for tablets, injections, powders, and solutions.
    Storage Store Cnidii Fructus Veterinary Grade API in a tightly sealed container, protected from light, moisture, and excessive heat. Keep in a cool, dry, well-ventilated area at temperatures below 25°C. Ensure the storage area is clean, free from contaminants, and not accessible to unauthorized personnel. Avoid storing with incompatible substances. Follow GMP guidelines for handling and inventory control.
    Application of Cnidii Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Cnidii Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    Our Cnidii Fructus Veterinary Grade API is widely adopted by commercial animal pharmaceutical producers for formulating finished dosage forms. Across ruminant, swine, and companion animal health sectors, this input supports standardized, traceable supply in compliance with major pharmacopoeias. Below, we detail its key industrial manufacturing applications, standards, tech-integration, and product outputs.

    1. Livestock Antiparasitic Tablet Manufacturing

    Major veterinary drug manufacturers utilize Cnidii Fructus extract as an active ingredient in the production of anti-ectoparasite tablets for swine, cattle, and sheep. This botanical API enters the blending stage after verified incoming QC and is dosed according to validated antiparasitic activity per batch standardization. Downstream partners require traceability to documented herbal identity and authorized extraction ratios, aligning with international veterinary monograph specifications. Manufacturers optimize extract content to balance parasite control with acceptance in target animal species, guided by farm practice and demonstrated safety margins.

    Industry compliance standards

    • Veterinary Pharmacopoeia of the People's Republic of China (2020 Edition)
    • European Pharmacopoeia Monograph on Veterinary Herbal Extracts
    • VICH GL55: Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • ISO 9001:2015 Quality Management System

    Typical usage ratio

    • 5%–15% API per tablet formulation, adjusted to meet prescribed dose and uniformity testing requirements, with precise ratio determined by target parasite species and pharmacodynamic assay data.

    Downstream process integration

    • Incorporation during the dry blend phase, post-sieving and humidity control, prior to wet granulation.
    • Followed by compression using rotary tablet presses, with in-process QC for content uniformity.
    • API identity and content verification by HPLC or TLC before batch release.
    • Supply chain tracking linked to farm-to-factory & lot release documentation.

    Final product types

    • Swine oral antiparasitic tablets
    • Cattle and sheep parasite control boluses
    • Combined dewormer/herb therapeutic tablets for ruminants
    • Private-label livestock formulations for integrators

    2. Veterinary Injection Solutions for Ectoparasite Control

    Pharmaceuticals manufacturers formulate injection solutions containing standardized Cnidii Fructus extract for rapid-onset control of external parasites in commercial animal operations. Extract batches undergo quality checks for concentration and endotoxin limits before entering solution compounding. GMP facilities blend the API with aqueous vehicles and preservatives at controlled temperatures, supporting sterile filling in ampoules or vials. Ratio and process controls reflect regulatory definitions for injectable veterinary products, with batch and sterile release documentation critical for national and export compliance.

    Industry compliance standards

    • Chinese Veterinary Drug GMP (2020 Revision)
    • US FDA 21 CFR part 514 (New Animal Drug Applications)
    • European Pharmacopoeia standards for Parenteral Preparations
    • Veterinary Herbal Injectable Specifications (National Product Registration Dossiers)

    Typical usage ratio

    • 2%–6% API per 100 mL solution, concentration adjusted to activity units/mL per finished batch release specification. Adjustments made based on target animal weight, parasite burden, and withdrawal period requirements.

    Downstream process integration

    • API dissolved in sterile water for injection with addition of sodium chloride and preservatives, under nitrogen atmosphere if required by monograph.
    • Compounded under Class 100 cleanroom conditions.
    • Sterile filtered (0.22 μm) prior to aseptic filling in ampoules or vials.
    • In-process bulk solution assay and post-fill sterility testing as per GMP batch records.

    Final product types

    • Cow and sheep injectable antiparasitic solutions
    • Multi-dose swine veterinary injectable vials
    • Compounded botanical plus synthetic antiparasitic cofomulations
    • Ready-to-administer bovine injectables for field veterinarians

    3. Functional Premix Blends for Animal Feed

    Animal nutrition firms in the feed additive sector introduce Cnidii Fructus extract into premix blends to deliver targeted pharmacological action in compound feed for poultry and livestock. Raw material entry focuses on uniform dispersion and compatibility with vitamins, minerals, and carrier matrices. Regulatory authorities oversee maximum permitted content and enforce batch-to-batch consistency testing, particularly where particular herbs are classified as feed additives in major markets. Premix ratios follow detailed process records, balanced for feed delivery method and species-specific intake patterns.

    Industry compliance standards

    • Ministry of Agriculture of China Feed Additive Catalog and Regulation
    • EU Feed Additive Regulation (EC) No 1831/2003
    • FAMI-QS Feed Ingredients Quality and Safety System
    • ISO 22000 Food Safety Management for Feedstuff

    Typical usage ratio

    • 0.2–1.0% (2–10 g/kg) in compound premix formulations, adjusted for age group, species, and integration with other active additives. Final content limited by national regulatory declarations.

    Downstream process integration

    • Powdered or granulated extract mixed with micro-ingredients and flow agents during premix homogenization.
    • Monitor blend uniformity by NIR or wet chemistry assay in QA lab before silo transfer.
    • Inclusion in mash or pelleted feed as per daily intake protocol and shelf-life validation.
    • Labeling per legal claims and withdrawal periods mandated by animal feed legislation.

    Final product types

    • Poultry functional premix additives
    • Swine feed blend concentrates
    • Dairy cattle health maintenance premix
    • Specialty animal feed supplements for small ruminants

    4. Veterinary Granule Formulation for Companion Animals

    Pet pharmaceutical manufacturers in Asia and select EU markets produce veterinary granule preparations incorporating Cnidii Fructus extract for companion animal health management, especially for dermatological and antiparasitic purposes. Extract must meet strict chemical purity and residual solvent criteria. It is incorporated during the granulation stage with excipients and flavoring agents, standardized to finished dose. Each batch undergoes extensive dissolution and uniformity testing to ensure safe, palatable dosing aligned with published pharmacopoeias for animals. Final packaging supports clear dosing and traceability for veterinary prescription.

    Industry compliance standards

    • Japanese Pharmacopoeia Veterinary Supplement Criteria
    • OIE (World Organisation for Animal Health) Feed and Drug Safety Guidelines
    • ISO 22716: Cosmetic GMP Guidelines (where applicable for pet products)
    • Local animal health product registration documentation

    Typical usage ratio

    • 3%–8% API w/w in total granule mass, adjusted by end-user animal weight and accepted veterinary dosing based on clinical studies and literature-based efficacy safety limits.

    Downstream process integration

    • API dry-mixed with excipients, followed by high-shear wet granulation and controlled fluid-bed drying.
    • Screened granules sized to target particle size distribution for dosing device compatibility.
    • Individual bulk and finished goods QC for assay, moisture, and palatability adherence.
    • Finished granules filled in sachets or jars with tamper-evident seals for commercial distribution.

    Final product types

    • Dog and cat oral antiparasite granules
    • Pet anti-pruritic and skin support granules
    • Over-the-counter animal supplement pouches
    • Veterinary prescription unit-dose granules

    Free Quote

    Competitive Cnidii Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Cnidii Fructus Veterinary Grade API: Advanced Plant-Based Solutions for Animal Health

    Introduction to Cnidii Fructus in the Veterinary Industry

    As the manufacturer behind Cnidii Fructus Veterinary Grade API, we have worked closely with veterinarians, animal nutritionists, and formulation experts to bring a genuinely reliable botanical ingredient to the animal health field. Cnidii Fructus holds a long heritage in herbal tradition, delivered from the fruit of Cnidium monnieri, widely recognized for its active compounds and benefits. Our team has focused on processing this plant material into pharmaceutical-grade active ingredients that meet consistently tight standards for safety, purity, and activity.

    Over the past decade, we have watched a shift in animal health, moving from synthetic-only interventions toward greater use of plant-based actives. Experience tells us this transition demands rigorous sourcing, steady analytical controls, and predictable bioactivity. We select our raw material from carefully audited growers, ensuring pesticide and heavy metal levels stay far below maximum regulatory limits. At harvest, our agronomy inspectors review every shipment; we test every batch before it reaches our GMP-certified production site.

    Specifications and Formulation Flexibility

    Our veterinary grade Cnidii Fructus API targets today's animal pharmaceutical requirements. We supply several models, each calibrated for applications like tablets, capsules, injections, powders, granules, premixes, and solutions. These forms recognize how product developers and veterinary professionals work—the form must support absorption, practical dosing, and animal acceptance.

    For solid dose forms (tablets, capsules, powders), we manufacture a free-flowing powder, typically standardized for osthole content—osthole is a well-documented natural coumarin with documented activity against a range of ectoparasites and pathogens relevant to animal health. Our assays confirm osthole at concentrations from 10% up to 99% (HPLC/dry basis), allowing veterinary formulators to customize dosing. Each batch comes with full-spectrum residual solvent, heavy metal, and microbial certificates, giving confidence to our downstream clients.

    Solution forms, often used in injectable or oral liquid products for livestock, need tight particle-size limits and clarity. We've invested in equipment to mill and filter extracts at scale, delivering a product with high solubility in common veterinary solvents (such as ethanol, propylene glycol, or water-glycerol blends). Our solution-grade extracts typically use pharmaceutical excipients to preserve and stabilize activity throughout the shelf life of the finished dosage form.

    Distinctive Features in Our Manufacturing Approach

    Working as a manufacturer gives us direct feedback from veterinarians, integrators, and feed mills. Product safety and repeated performance mean more than ticking boxes in a specification. Our technical teams routinely revalidate process lines to make sure our customers don't deal with sedimentation, clumping, or extraction residue in finished medicines. Every kilogram is tracked from the farm to the finished drum. That traceability doesn't come from reselling or repacking—it is built into our process, because we set up the controls and run the reactors ourselves.

    We've seen the pitfalls that show up with lower-grade herbal extracts from the open market, including erratic content of active compounds or hidden impurities, especially when older, improvised extraction techniques are used. We moved to closed-loop, automated percolation and multistep filtration years ago, minimizing operator error and batch-to-batch drift. Resulting extracts show consistently strong activity in lab and field testing. Water content and residual solvents stay well below accepted animal pharmaceutical levels, giving a longer shelf life and reducing risk of spoilage or cross-reaction.

    How Cnidii Fructus API Works in Animal Health

    Veterinary researchers and field veterinarians often come to us seeking natural alternatives or complements to chemical antiparasitics and antibiotics. Cnidii Fructus contains several active compounds, but osthole stands out for its multi-pathway activity. In laboratory trials, osthole has shown marked effect against skin parasites such as Sarcoptes mites and ticks, which are persistent problems in commercial livestock and companion animals. It achieves this through alteration of neurotransmitter signaling in pest organisms, leading to their loss of mobility and eventual elimination.

    Beyond direct antiparasitic action, some clients are interested in the product for its potential support in wound healing, skin health, and addressing certain fungal skin infections. These claims stem from traditional uses and a growing number of published veterinary studies. Our direct supply chain lets us track, sample, and analyze for these secondary metabolites, providing more precise chemotype profiles than many competitors, especially those depending on bulk-market intermediaries.

    Usage Scenarios: Formulation to Field Practice

    Veterinary pharmaceutical companies, contract manufacturers, commercial poultry and livestock integrators—each of these partners brings different technical expectations for the API. Over years of scale-up and production, our teams have observed a few critical success factors:

    Quality Assurance and Regulatory Trust

    Compliance demands concrete, verifiable steps. We never buy extract intermediates from the market; all API passes through certified in-process controls at our own facility, under continuous monitoring. That means clients have access to full analytical data across all major contaminant classes—pesticide residues, heavy metals (lead, arsenic, mercury, cadmium), microbiological load (TPC, yeast, mold, coliforms), and validated active assay.

    Depending on the export market, our Cnidii Fructus API supports dossiers for regulatory authorities in regions such as the European Union, North America, ASEAN, and key Middle Eastern states. Documentation goes far beyond a basic certificate of analysis—we can supply source traceability, process validation reports, and full impurity profiling. Experience shows this paperwork isn’t just bureaucracy; it speeds up time to market for our clients, especially when their auditors demand verification.

    Comparing Our Product with Other Options

    Direct sourcing, proprietary extraction, and computerized process controls set our veterinary Cnidii Fructus API apart from loosely specified market products. One recurring complaint we hear from industry partners about generic, commodity-grade API involves drifting actives, poor solubility, and off-spec contamination. Ingredients shipped in bulk bags from unknown factories bring risk that only shows up in failed tablet runs, field efficacy trials, or regulatory spot checks.

    In our experience, low-quality extracts generate more headaches than savings. Powder that clumps, carries excessive residual solvent, or fluctuates in osthole levels can force recall, costly rework, or underwhelming clinical results in animals. With our process, these issues get controlled at the extraction tank, and our on-site QC lab confirms every drum before shipment. Feedback from long-term partners tells us that paying closer attention to starting material, process steps, and consistency keeps their lines running smoothly. They report fewer out-of-spec batches and more predictable finished product yields.

    Sustainable, Ethical Supply Chains Matter

    Sourcing for animal health no longer means accepting anything labeled as a plant extract. Ethical expectations keep rising in veterinary pharma, especially for export. We work directly with partner growers, using fair-trade principles, strict no-child-labor policies, and crop rotation to protect soil health. Transparent grower relationships mean we can arrange third-party audits, trace every consignment to field coordinates, and prevent issues before they ever reach our gates.

    Resource efficiency gets treated as a real metric on our side, not a marketing claim. Closed-loop solvent recovery, in-house water recycling, and minimized energy use by batch scheduling—small steps add up across thousands of kilos every year. We believe quality, safety, and ethics in plant-based APIs are intertwined; shortcuts on any side undermine trust. Our long-term clients who visit facility audits see those standards in practice every day, not just on paper.

    Working Closely with Veterinarians and Formulators

    Veterinary medicine always brings evolving challenges. New parasite resistance, shifting market regulatory limits, emerging diseases—we hear these concerns in person from our partners, not from trade magazines. Over years of direct collaboration, we've refined particle sizing for better absorption in oral drugs and improved extract stability for injectables, based on real formulator feedback from working professionals in the field.

    Once, a major poultry producer reported intermittent clogging in a medicated water application. Our process engineers worked with their technical staff for several cycles, adjusting filtration mesh size and running real-time stability simulations under their water conditions. The final result eliminated all visible sedimentation, with the active profile unchanged. These “minor” fixes mark the difference between academic-grade ingredients and practical, field-tested APIs.

    For injectable use, shelf life and clarity matter. Formulators get direct support from us on excipient compatibility, anticipating what will and won't pass down the line in real-world animal clinics. We recognize supply schedules in the animal health arena don’t wait for factory convenience—the reality of disease outbreaks, mass medicating, or acute animal welfare issues demand reliable delivery. Advance booking, flexible batch sizes, and QA records ready for inspection ensure our customers can act fast and stay compliant.

    Potential Challenges and Solutions in Application

    No plant-based API, no matter how rigorously prepared, is immune to market realities. We've seen three main concerns raised repeatedly in the veterinary world: batch activity drift from harvest year variation, perceived issues with API solubility or formulating stability, and skepticism from end clients if the botanical approach will match or outperform synthetic analogues. Our approach relies on continual process alignment and open technical support.

    Year-on-year variation in active content troubles many herb sources. By mixing calibrated batches, multipoint sampling, and process tuning, we stabilize the key actives within a tight range. We never mix old and new crop indiscriminately, unlike bulk traders. If a grow year brings weaker actives, we flag it at intake and adjust our extraction yield targets. Clients who've dealt with erratic herbal APIs know this step cuts variability that can otherwise ruin a run of medicated feed or finished drug.

    Solubility, especially for high-load solutions or injectable products, challenges even seasoned formulators. We don’t just supply a powder—we offer pre-solubilized forms, with validated compatibility data for major injectable excipients and preservatives. Over countless formulation support calls and joint bench tests, we pinpoint which co-solvents and diluents actually deliver clear, stable solutions across temperature changes and storage time.

    Skepticism about real-world outcomes can only be addressed with trial data. We support field evaluations, sharing anonymized case results from partner farms and clinics. Field veterinarians who’ve tried our API in mite treatments, or as an adjunct in skin therapy, often become repeat clients, sharing outcome records that help us fine-tune future production lots.

    Conclusion: Building the Future of Botanical Veterinary Medicines

    Being the actual manufacturer, not just a middleman, means building expertise one process step and one partnership at a time. As more veterinary professionals and pharmaceutical developers seek proven, consistently manufactured plant-based APIs, the sources they depend on must go far beyond paperwork or basic testing. Our team continues to invest in science-backed, field-validated, regulatory-ready Cnidii Fructus Veterinary Grade API for the full range of solid and liquid animal dosage forms. Quality starts on the farm, travels through the lab, and finishes in the hands of the veterinarians who drive animal health forward every day.

    Top